Advanced Modalities
Analytical & Bioanalytical Services
Clinical Trial Supply & Logistics
Regulatory, Tech Transfer & Support Services
Company Overview
About
Takara Bio is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:Japan
Founded:2003
Employees:2,533
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval CB7O80
EMA · #APR-BTPVKCQU · 2021-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-Z7GVU3EF
Issued: 2020-02-01
Expires: 2025-08-25
WHO GMP
World Health Organization
Cert #: CERT-8LC61R1O
Issued: 2020-09-18
Expires: 2025-11-06
Loading CDMO intelligence...
Key facts about Takara Bio
- Takara Bio is headquartered in Japan.
- Takara Bio was founded in 2003.
- Takara Bio has 2,533 employees.
- Takara Bio's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Takara Bio
Directory pages this company appears in, each with the full list of matching manufacturers.